The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of baseline and concomitant corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
 
David James Pinato
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Mina Therapeutics; Mina Therapeutics; Mina Therapeutics; Mina Therapeutics
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; ViiV Healthcare; ViiV Healthcare; ViiV Healthcare; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences
Honoraria - Bayer Health; Bayer Health; Bayer Health; Bayer Health; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; Bayer Health; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Research Funding - Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Genentech; Genentech; Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
 
Yinghong Wang
Consulting or Advisory Role - Tillotts Pharma; Tillotts Pharma; Tillotts Pharma; Tillotts Pharma
 
Anwaar Saeed
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
 
David Szafron
No Relationships to Disclose
 
Tomi Jun
No Relationships to Disclose
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
ChiehJu Lee
No Relationships to Disclose
 
Uqba Khan
Honoraria - Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health; Conquer Cancer Foundation; Conquer Cancer Foundation; Conquer Cancer Foundation; Conquer Cancer Foundation
 
Neil Satish Nimkar
No Relationships to Disclose
 
Sonal Paul
No Relationships to Disclose
 
Dominik Bettinger
No Relationships to Disclose
 
Hannah Hildebrand
No Relationships to Disclose
 
Tiziana Pressiani
No Relationships to Disclose
 
Yehia I. Abugabal
No Relationships to Disclose
 
Nicola Personeni
No Relationships to Disclose
 
Yi-Hsiang Huang
No Relationships to Disclose
 
Lorenza Rimassa
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Eisai; Eisai; Eisai; Eisai; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; ArQule; ArQule; ArQule; ArQule; Baxter; Baxter; Baxter; Baxter; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Hengrui Therapeutics; Hengrui Therapeutics; Hengrui Therapeutics; Hengrui Therapeutics; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; Italfarmaco; Italfarmaco; Italfarmaco; Italfarmaco; Lilly; Lilly; Lilly; Lilly; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; ArQule; ArQule; ArQule; Ipsen; Ipsen; Ipsen; Ipsen
 
Celina Ang
No Relationships to Disclose
 
Thomas Urban Marron
Consulting or Advisory Role - Atara Biotherapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Genentech; Genentech; Genentech; Genentech; Regeneron; Regeneron; Regeneron; Regeneron
Research Funding - Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Genentech; Genentech; Genentech; Genentech